Strategies for Temporary Mechanical Support: Contemporary Experience with Pulsatile and Non-pulsatile Support Systems
Despite advances in mechanical circulatory support, cardiogenic shock continues to have a high mortality. We reviewed our experience with pulsatile versus non-pulsatile temporary mechanical support at our institution to determine optimal strategy for survival.
From January 2001 to December 2003, mechanical support for cardiogenic shock was instituted in 38 patients.
Non-pulsatile devices (NP group) were used in 22 patients and pulsatile devices (P group) in 16 patients. Indications for the NP group were post-cardiotomy shock (PCS) in 17, myocardial infarction in 2, and isolated post-cardiotomy right ventricular failure in 3 patients. In the P group, 9 had the device placed for PCS, 3 for viral myocarditis, 1 after myocardial infarction, and 3 for right ventricular (RV) failure. Overall, bleeding, limb ischemia, and multi-system organ failure were higher in NP group with 5 weaned and 3 surviving to discharge (14%). In the P group, survivors included 7 weaned and 3 transplanted patients (63%).
With the exception of isolated RV failure, we obtained a dismal survival result with ECMO/centrifugal circuits for treatment of cardiogenic shock. For refractory pump failure, improved survival was achieved by using intermediate-term pulsatile devices with early transition to a chronic device and/or heart transplantation.
Smedira NG, Moazami N, Golding CM, et al. 2001. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 122:92-102.nDembitsky W. 1999. Bridging from acute to chronic devices. Ann Tho-rac Surg 68:724-8.nDoll N, Kiaii B, Borger M, et al. 2004. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 77:151-7.nDeRose JJ, Slater JP, Spanier TB, et al. 1999. Improved survival rates support left ventricular assist device implantation early after myocardial infarction. J Am Col Card 33(7):1903-8.nDiGiorgi PL, Rao V, Naka Y, et al. 2003. Which patient, which pump? J Heart Lung Transplant 22:221-33.nECLS registry report. International Summary. July 2001. Extracorporeal Life Support Organization.nGolding LA, Crouch RD, Stewart RW, et al. 1992. Postcardiotomy centrifugal mechanical ventricular support. Ann Thorac Surg 54:1059-64.nHelman DN, Morales DLS, Edwards NM, et al. 1999. Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg 68(4):1187-94.nHoy FBY, Mueller DK, Geiss DM, et al. 2000. Bridge to recovery for postcardiotomy failure: is there still a role for centrifugal pumps? Ann Thorac Surg 70:1259-63.nKo WJ, Lin CY, Chen RJ, et al. 2002. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 73:538-45.nKörfer R, El-Banayosy A, Arusoglu L, et al. 1999. Temporary pulsatile ventricular assist devices and biventricular assist devices. Ann Thorac Surg 68:678-83.nMoazami N, Smedira NG. 2001. Temporary mechanical support. J Card Surg 16(3):193-202.nMoazami N, Moon MR, Lawton JS, et al. 2003. Axillary artery cannulation for extracorporeal membrane oxygenator support in adults: An approach to minimize complications. J Thorac Cardiovasc Surg 6(126): 2097-8.nMoazami N, Pasque MK, Moon MR, et al. 2004. Mechanical support for isolated right ventricular failure in post-cardiotomy patients. J Heart Lung Transplant 23(12):1371-5.nMorgan JA, Stewart AS, Lee BJ, et al. 2004. Role of the Abiomed BVS 5000 device for short-term support and bridge to transplantation. ASAIO Journal 50(4):360-3.nPae WE, Jr, Miller CA, Matthews Y, et al. 1992. Ventricular assist devices for post cardiotomy cardiogenic shock: a combined registry experience. J Thorac Cardiovasc Surg 104(3):541-3.nPagani FD, Aaronson KD, Dyke DB, et al. 2000. Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy. Ann Thorac Surg 70:1977-85.nPeek GJ, Firmin RK. 1999. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J 45(4):250-63.nPennington DG, Smedira NG, Samuels LE, et al. 2001. Mechanical circulatory support for acute heart failure. Ann Thorac Surg 71:S56-9.nSamuels LE, Holmes EC, Thomas MP, et al. 2001. Management of acute cardiac failure with mechanical assist: experience with the Abiomed BVS 5000. Ann Thorac Surg 71(3 Suppl):S67-72.nSmedira NG, Blackstone EH. 2001. Postcardiotomy mechanical support: risk factors and outcomes. Ann Thorac Surg 71:S60-6.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).